SCHEMBL4374793

SCHEMBL4374793

CC(C)NC[C@H](O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4139553 1.00
SCHEMBL4373913 1.00
Acetone SCHEMBL10800590 0.91 ADRB2 (0.42)
SCHEMBL15509647 0.85 ADRB2 (0.47)
SCHEMBL3037240 0.83
Hydrochloric Acid SCHEMBL28213102 0.81 LMNA (0.40)
SCHEMBL26075439 0.80 ADRB2 (0.42)
SCHEMBL15058641 0.79 THRB (0.43)
SCHEMBL25554707 0.79 LMNA (0.33)
SCHEMBL25554534 0.79 LMNA (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0339006-B1 PROCESS FOR PREPARING S-METOPROLOL AND INTERMEDIATES THEREFOR Astra Pharmaceutical Production AB (SE) 1992-07-08 EP claimed
US-5034535-A Multistage reaction with chloroformate ester and isopropylamino-1,2-propanediol for cyclization, sulfonation and etherification ASTRA PHARMACEUTICAL PRODUCTION AKTIEBOLAG (SE) 1991-07-23 US claimed
EP-0339006-A1 Process for preparing S-metoprolol and intermediates therefor Astra Pharmaceutical Production AB (SE) 1989-10-25 EP claimed
JP-2022253-A None JP disclosed
EP-3998260-B1 SGC STIMULATORS CYCLERION THERAPEUTICS INC (US) 2023-11-01 EP disclosed
US-20230303494-A1 BENZYLAMINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF ACADEMY OF MILITARY MEDICAL SCIENCES (CN) 2023-09-28 US disclosed
US-20230255945-A1 FORMULATIONS OF PYRROLOPYRIDINE-ANILINE COMPOUNDS NFLECTION THERAPEUTICS, INC. 2023-08-17 US disclosed
US-20230255945-A1 FORMULATIONS OF PYRROLOPYRIDINE-ANILINE COMPOUNDS NFLECTION THERAPEUTICS, INC. 2023-08-17 US disclosed
CN-109369635-B Compound or pharmaceutically acceptable salt thereof, application thereof and pharmaceutical composition 赛克里翁治疗有限公司 2023-06-30 CN disclosed
EP-4198017-A1 BENZYLAMINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF Academy of Military Medical Sciences (CN) 2023-06-21 EP disclosed
US-20230106002-A1 sGC STIMULATORS IRONWOOD PHARMACEUTICALS, INC. 2023-04-06 US disclosed
WO-2000047212-A1 QUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ASTRAZENECA AB (SE) 2000-08-17 WO disclosed
EP-0339006-B1 PROCESS FOR PREPARING S-METOPROLOL AND INTERMEDIATES THEREFOR Astra Pharmaceutical Production AB (SE) 1992-07-08 EP disclosed
US-5034535-A Multistage reaction with chloroformate ester and isopropylamino-1,2-propanediol for cyclization, sulfonation and etherification ASTRA PHARMACEUTICAL PRODUCTION AKTIEBOLAG (SE) 1991-07-23 US disclosed
US-5034535-A Multistage reaction with chloroformate ester and isopropylamino-1,2-propanediol for cyclization, sulfonation and etherification ASTRA PHARMACEUTICAL PRODUCTION AKTIEBOLAG (SE) 1991-07-23 US disclosed
JP-H0222253-A PRODUCTION OF S-METHOPROLOL ASTRA PHARMACEUT PROD AB 1990-01-25 JP disclosed
EP-0339006-A1 Process for preparing S-metoprolol and intermediates therefor Astra Pharmaceutical Production AB (SE) 1989-10-25 EP disclosed
EP-0339006-A1 Process for preparing S-metoprolol and intermediates therefor Astra Pharmaceutical Production AB (SE) 1989-10-25 EP disclosed
US-4031125-A 3-Sulfonate ester of 2,3-dihydroxypropylamine MERCK & CO., INC. (US) 1977-06-21 US disclosed
US-3962338-A Novel methods and compounds employed therein MERCK & CO., INC. (US) 1976-06-08 US disclosed